Cell death: protein misfolding and neurodegenerative diseases

被引:140
|
作者
Nakamura, Tomohiro [1 ]
Lipton, Stuart A. [1 ,2 ]
机构
[1] Burnham Inst Med Res, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA
[2] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92039 USA
关键词
S-Nitrosylation; Molecular chaperone; Ubiquitin-proteasome system; Protein misfolding; Neurodegeneration; NITRIC-OXIDE SYNTHASE; ENDOPLASMIC-RETICULUM STRESS; METHYL-D-ASPARTATE; UBIQUITIN LIGASE ACTIVITY; PARKINS PROTECTIVE FUNCTION; DISULFIDE-ISOMERASE FAMILY; LONG-TERM POTENTIATION; NMDA RECEPTOR-ACTIVITY; LEWY-BODY FORMATION; S-NITROSYLATION;
D O I
10.1007/s10495-008-0301-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several chronic neurodegenerative disorders manifest deposits of misfolded or aggregated proteins. Genetic mutations are the root cause for protein misfolding in rare families, but the majority of patients have sporadic forms possibly related to environmental factors. In some cases, the ubiquitin-proteasome system or molecular chaperones can prevent accumulation of aberrantly folded proteins. Recent studies suggest that generation of excessive nitric oxide (NO) and reactive oxygen species (ROS), in part due to overactivity of the NMDA-subtype of glutamate receptor, can mediate protein misfolding in the absence of genetic predisposition. S-Nitrosylation, or covalent reaction of NO with specific protein thiol groups, represents one mechanism contributing to NO-induced protein misfolding and neurotoxicity. Here, we present evidence suggesting that NO contributes to protein misfolding via S-nitrosylating protein-disulfide isomerase or the E3 ubiquitin ligase parkin. We discuss how memantine/NitroMemantine can inhibit excessive NMDA receptor activity to ameliorate NO production, protein misfolding, and neurodegeneration.
引用
收藏
页码:455 / 468
页数:14
相关论文
共 50 条
  • [41] Protein misfolding and medicinal strategies in neurodegenerative disorders
    Mehboudi, Leila
    Zahedirad, Mehrshad
    Vadiei, Parisa
    MEDICINA BALEAR, 2022, 37 (04): : 166 - 170
  • [42] Protein folding and misfolding in the neurodegenerative disorders: A review
    Boshette, N. B.
    Thakur, K. K.
    Bidkar, A. P.
    Trandafir, C.
    Kumar, P.
    Gogoi, R.
    REVUE NEUROLOGIQUE, 2014, 170 (03) : 151 - 161
  • [43] Cell Death and Neurodegenerative Diseases: Mechanisms and Cytoprotective Molecules
    Vejux, Anne
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [44] TSPO AND CELL DEATH IMPLICATIONS FOR CANCER AND NEURODEGENERATIVE DISEASES
    Gavish, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 10 - 10
  • [45] Neuronal Cell Death Mechanisms in Major Neurodegenerative Diseases
    Chi, Hao
    Chang, Hui-Yun
    Sang, Tzu-Kang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (10)
  • [46] Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death
    Gonatas, Nicholas K.
    Stieber, Anna
    Gonatas, Jacqueline O.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 246 (1-2) : 21 - 30
  • [47] Apoptosis as a general cell death pathway in neurodegenerative diseases
    Offen, D
    Elkon, H
    Melamed, E
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2000, (58): : 153 - 166
  • [48] HORMESIS, CELL DEATH, AND REGENERATIVE MEDICINE FOR NEURODEGENERATIVE DISEASES
    Wang, Guanghu
    DOSE-RESPONSE, 2013, 11 (02): : 238 - 254
  • [49] Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
    Guo, Dong
    Liu, Zhihao
    Zhou, Jinglin
    Ke, Chongrong
    Li, Daliang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [50] Apoptosis as a general cell death pathway in neurodegenerative diseases
    Offen, D
    Elkon, H
    Melamed, E
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 7, 2000, 7 : 153 - 166